295 related articles for article (PubMed ID: 16827889)
1. Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia.
Haiat S; Billard C; Quiney C; Ajchenbaum-Cymbalista F; Kolb JP
Immunology; 2006 Jul; 118(3):281-92. PubMed ID: 16827889
[TBL] [Abstract][Full Text] [Related]
2. BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features.
Bojarska-Junak A; Hus I; Chocholska S; Wasik-Szczepanek E; Sieklucka M; Dmoszyńska A; Roliński J
Leuk Res; 2009 Oct; 33(10):1319-27. PubMed ID: 19395025
[TBL] [Abstract][Full Text] [Related]
3. The BAFF/APRIL system: life beyond B lymphocytes.
Ng LG; Mackay CR; Mackay F
Mol Immunol; 2005 May; 42(7):763-72. PubMed ID: 15829264
[TBL] [Abstract][Full Text] [Related]
4. The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers.
Mackay F; Tangye SG
Curr Opin Pharmacol; 2004 Aug; 4(4):347-54. PubMed ID: 15251127
[TBL] [Abstract][Full Text] [Related]
5. B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL.
Ferrer G; Bosch R; Hodgson K; Tejero R; Roué G; Colomer D; Montserrat E; Moreno C
Br J Haematol; 2014 Feb; 164(4):570-8. PubMed ID: 24245956
[TBL] [Abstract][Full Text] [Related]
6. Novel function of TNF cytokines in regulating bone marrow B cell survival.
Zhang M; Ko KH; Lam QL; Lo CK; Xu DJ; Shen L; Zheng B; Srivastava G; Lu L
Cell Mol Immunol; 2004 Dec; 1(6):447-53. PubMed ID: 16293214
[TBL] [Abstract][Full Text] [Related]
7. The uncertain glory of APRIL.
Medema JP; Planelles-Carazo L; Hardenberg G; Hahne M
Cell Death Differ; 2003 Oct; 10(10):1121-5. PubMed ID: 14502235
[TBL] [Abstract][Full Text] [Related]
8. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway.
Kern C; Cornuel JF; Billard C; Tang R; Rouillard D; Stenou V; Defrance T; Ajchenbaum-Cymbalista F; Simonin PY; Feldblum S; Kolb JP
Blood; 2004 Jan; 103(2):679-88. PubMed ID: 14504101
[TBL] [Abstract][Full Text] [Related]
9. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
[TBL] [Abstract][Full Text] [Related]
10. An APRIL to remember: novel TNF ligands as therapeutic targets.
Dillon SR; Gross JA; Ansell SM; Novak AJ
Nat Rev Drug Discov; 2006 Mar; 5(3):235-46. PubMed ID: 16474316
[TBL] [Abstract][Full Text] [Related]
11. Release of interleukin-6 in cultured B-chronic lymphocytic leukaemia cells is associated with both activation and cell death via apoptosis.
Büssing A; Stein GM; Stumpf C; Schietzel M
Anticancer Res; 1999; 19(5B):3953-9. PubMed ID: 10628337
[TBL] [Abstract][Full Text] [Related]
12. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha.
Nishio M; Endo T; Tsukada N; Ohata J; Kitada S; Reed JC; Zvaifler NJ; Kipps TJ
Blood; 2005 Aug; 106(3):1012-20. PubMed ID: 15860672
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukemia cells.
Sanz L; Garcia-Marco JA; Casanova B; de La Fuente MT; García-Gila M; Garcia-Pardo A; Silva A
Biochem Biophys Res Commun; 2004 Mar; 315(3):562-7. PubMed ID: 14975737
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin and cytokines: focus on tumor necrosis factor family members BAFF and APRIL.
Le Pottier L; Sapir T; Bendaoud B; Youinou P; Shoenfeld Y; Pers JO
Ann N Y Acad Sci; 2007 Sep; 1110():426-32. PubMed ID: 17911457
[TBL] [Abstract][Full Text] [Related]
15. BAFF, APRIL and human B cell disorders.
Tangye SG; Bryant VL; Cuss AK; Good KL
Semin Immunol; 2006 Oct; 18(5):305-17. PubMed ID: 16916610
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
17. Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils.
Scapini P; Bazzoni F; Cassatella MA
Immunol Lett; 2008 Feb; 116(1):1-6. PubMed ID: 18155301
[TBL] [Abstract][Full Text] [Related]
18. BAFF: a fundamental survival factor for B cells.
Mackay F; Browning JL
Nat Rev Immunol; 2002 Jul; 2(7):465-75. PubMed ID: 12094221
[TBL] [Abstract][Full Text] [Related]
19. Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor.
Deshayes F; Laprée G; Portier A; Richard Y; Pencalet P; Mahieu-Caputo D; Horellou P; Tsapis A
Oncogene; 2004 Apr; 23(17):3005-12. PubMed ID: 14691452
[TBL] [Abstract][Full Text] [Related]
20. A novel bioassay for B-cell activating factor (BAFF) based on expression of a BAFF-receptor ectodomain-tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-2 endodomain fusion receptor in human rhabdomyosarcoma cells.
McClements M; Williams S; Ball C; Bristow A; Wadhwa M; Meager A
J Immunol Methods; 2008 Aug; 337(1):63-70. PubMed ID: 18625509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]